Lopez Derrick, Dwivedi Girish, Nossent Johannes, Preen David B, Murray Kevin, Raymond Warren, Inderjeeth Charles, Keen Helen I
The University of Western Australia, Crawley, Western Australia, Australia.
The University of Western Australia, Crawley, Fiona Stanley Hospital, Murdoch, and Harry Perkins Institute of Medical Research, Western Australia, Australia.
ACR Open Rheumatol. 2023 Jun;5(6):298-304. doi: 10.1002/acr2.11540. Epub 2023 May 11.
Cardiovascular disease is the most common cause of death in people with gout. Acute inflammation, which is a characteristic of gout, may have a mechanistic role in major adverse cardiovascular events (MACEs). We aimed to examine the relationship between admissions to a hospital with acute gout and MACEs in a large population-based data set.
We extracted data from the Hospital Morbidity Data Collection and Death Registrations of the Western Australian Rheumatic Disease Epidemiology Registry. We identified patients admitted to hospital with incident acute gout and who had admissions or a death record because of MACEs. We compared the risk of MACEs during the postdischarge period (1-30 days after acute gout admission) and control period (365 days prior to admission and 365 days after the postdischarge period) using a self-controlled case-series (SCCS) design, which is a within-person design that controls for time-invariant patient-specific confounding. We performed conditional fixed-effects Poisson regression to obtain rate ratios (RRs).
We identified 941 patients (average age: 76.4 years; SD: 12.6; 66.7% male) with an incident acute gout admission and documented MACEs during the control and/or postdischarge periods. Of the 941 patients, 898 (95%) experienced MACEs during the combined control period (730-day period) and 112 (12%) during the postdischarge period (30-day period). The rates of MACEs during the total control and postdischarge periods were 0.84 and 1.45 events per person-year, respectively. Regression analysis confirmed increased rate during the postdischarge period (RR: 1.67; 95% CI: 1.38-2.03) compared with the control period. Sensitivity analyses indicated that our results were robust in relation to known limitations of the SCCS design.
We report an increased risk of MACEs in the first 30 days after an incident hospital admission with acute gout, suggesting a temporal association between acute inflammation and subsequent MACEs in patients with gout.
心血管疾病是痛风患者最常见的死亡原因。急性炎症是痛风的一个特征,可能在主要不良心血管事件(MACE)中起作用。我们旨在研究基于大量人群的数据集里,急性痛风入院与MACE之间的关系。
我们从西澳大利亚风湿病流行病学登记处的医院发病率数据收集和死亡登记中提取数据。我们确定了因新发急性痛风入院且因MACE有入院或死亡记录的患者。我们使用自我对照病例系列(SCCS)设计比较了出院后时期(急性痛风入院后1 - 30天)和对照期(入院前365天和出院后时期后365天)发生MACE的风险,SCCS设计是一种个体内设计,可控制时间不变的患者特异性混杂因素。我们进行了条件固定效应泊松回归以获得率比(RRs)。
我们确定了941例因新发急性痛风入院且在对照期和/或出院后时期有记录的MACE的患者(平均年龄:76.4岁;标准差:12.6;66.7%为男性)。在这941例患者中,898例(95%)在合并对照期(730天)发生了MACE,112例(12%)在出院后时期(30天)发生了MACE。对照期和出院后时期MACE的发生率分别为每人年0.84次和1.45次事件。回归分析证实出院后时期的发生率与对照期相比有所增加(RR:1.67;95%置信区间:1.38 - 2.03)。敏感性分析表明,我们的结果对于SCCS设计的已知局限性具有稳健性。
我们报告了因急性痛风入院后的前30天内发生MACE的风险增加,提示痛风患者急性炎症与随后的MACE之间存在时间关联。